Monocyte locomotion inhibitory factor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 7, 2009
Grant Date -
Dec 23, 2004
app pub date -
Jun 4, 2004
filing date -
Jun 29, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to an anti-inflammatory oligopeptides which contain the terminal pharmacophore Cys-Asn-Ser which is capable of inhibiting the NF-κβ signaling pathway. The oligopeptides are useful in stimulating the in vivo production of IL-10, and for treating inflammatory diseases and scarring when formulated in pharmaceutical compositions for administration to patients.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully